NCT00058903已完成2 期
Treatment of Cholestatic Pruritus With Sertraline
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2003年4月最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
研究概览
简要总结
The goal of this study is to find an effective and well-tolerated medical therapy for itching due to liver disease. Persons with primary biliary cirrhosis or chronic hepatitis C are currently being enrolled in the study. Persons participating in the study are given sertraline, a medication which is also often used for depression,to treat their itching. The dose is gradually increased as the effect on itching and any other potential side effects are carefully monitored.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Colesevelam Versus Placebo in Cholestatic PruritusChronic Liver DiseaseNCT00756171Foundation for Liver Research38
已完成
4 期
Sertraline and Habit Reversal in the Treatment of Patients With TrichotillomaniaImpulse Control DisordersNCT00118014Massachusetts General Hospital75
已完成
3 期
Gabapentin to Treat Itch in Patients With Liver DiseaseCholestasisItchingCirrhosisPruritusLiver DiseaseNCT00058890National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)15
已完成
2 期
Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 3NCT02227823Centre Hospitalier Régional de la Citadelle4
Unknown
3 期
The Effect of Bezafibrate on Cholestatic ItchSecondary Sclerosing CholangitisPrimary Sclerosing CholangitisPrimary Biliary CholangitisNCT02701166Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)84